» Articles » PMID: 36937566

Luteolin: A Promising Natural Agent in Management of Pain in Chronic Conditions

Overview
Date 2023 Mar 20
PMID 36937566
Authors
Affiliations
Soon will be listed here.
Abstract

Pain due to chronic conditions is a frequent and insufficiently addressed problem. Current drug options for pain management (either in cases of chronic inflammatory conditions or neuropathy) do not adequately treat pain. Moreover, they are associated with important adverse events in long term use. Luteolin is a flavonoid widely present in the plant kingdom and its sources have been assembled in a comprehensive list of this paper. Luteolin has shown in several research studies a range of pharmacological properties; anti-inflammatory, antioxidant, neuroprotective, and analgesic. In this article, we summarize the effects and potential benefits from introducing luteolin as an adjuvant agent in established protocols for pain management. We review the most indicative and evidence of how luteolin can target the molecular pathways involved in pathogenesis of chronic inflammatory and neuropathic pain. The data reviewed strongly support luteolin's promising benefits in pain management and raise the need for further clinical trials that can establish its role in clinical practice.

Citing Articles

Nitroxidative Stress, Cell-Signaling Pathways, and Manganese Porphyrins: Therapeutic Potential in Neuropathic Pain.

Silva A, de Lavor M Int J Mol Sci. 2025; 26(5).

PMID: 40076672 PMC: 11900433. DOI: 10.3390/ijms26052050.


Research Progress on Anti-Inflammatory Mechanism of .

Wu N, Wang S, Zhang Y, Wang S Int J Mol Sci. 2025; 26(5).

PMID: 40076538 PMC: 11900443. DOI: 10.3390/ijms26051911.


Neuroprotective Potential of L. Essential Oil Against Scopolamine-Induced Memory Deficits and Oxidative Stress in a Zebrafish Model.

Brinza I, Boiangiu R, Honceriu I, Abd-Alkhalek A, Osman S, Eldahshan O Biomolecules. 2025; 15(1).

PMID: 39858532 PMC: 11762835. DOI: 10.3390/biom15010138.


Repurposed Drugs and Plant-Derived Natural Products as Potential Host-Directed Therapeutic Candidates for Tuberculosis.

Raqib R, Sarker P Biomolecules. 2025; 14(12.

PMID: 39766204 PMC: 11673177. DOI: 10.3390/biom14121497.


Progress of research into microglial mediation of central post-stroke pain.

Li Y, Dang Z, Li S, Li G, Cai H, Lu Y Int J Immunopathol Pharmacol. 2024; 38:3946320241309220.

PMID: 39699048 PMC: 11660280. DOI: 10.1177/03946320241309220.


References
1.
Sanchez de Rojas V, Somoza B, Ortega T, Villar A . Isolation of vasodilatory active flavonoids from the traditional remedy Satureja obovata. Planta Med. 1996; 62(3):272-4. DOI: 10.1055/s-2006-957876. View

2.
Wu Q, Li Y, Shi Y . Antioxidant phenolic glucosides from Gentiana piasezkii. J Asian Nat Prod Res. 2006; 8(5):391-6. DOI: 10.1080/10286020500172368. View

3.
Kamel M, Mohamed K, Hassanean H, Ohtani K, Kasai R, Yamasaki K . Iridoid and megastigmane glycosides from Phlomis aurea. Phytochemistry. 2000; 55(4):353-7. DOI: 10.1016/s0031-9422(00)00331-9. View

4.
Kim D . Antioxidative components from the aerial parts of Lactuca scariola L. Arch Pharm Res. 2001; 24(5):427-30. DOI: 10.1007/BF02975189. View

5.
Park E, Kim Y, Kim J . Acylated flavonol glycosides from the flower of Inula britannica. J Nat Prod. 2000; 63(1):34-6. DOI: 10.1021/np990271r. View